HQIP NCA 148 Medical and Surgical Clinical Outcome Review Programme.

Descriptions

1. BackgroundThe Healthcare Quality Improvement Partnership (HQIP) has been requested to commission the Medical and Surgical Clinical Outcome Review Programme on behalf of NHS England, DHSSPS Northern Ireland, the Welsh Government, the Channel Islands and the Isle of Man.The Medical and Surgical Programme is 1 of 4 Clinical Outcome Review Programmes (previously known as confidential enquiries) which are designed to help assess the quality of healthcare, and stimulate improvement in safety and effectiveness by systematically enabling clinicians, managers and policy makers to learn from adverse events and other relevant data.The other programmes are:— The Mental Health Programme;— The Maternal Newborn and Infant Programme;— The Child Health Programme.The programmes aim to complement and contribute to the work of other agencies such as NICE, CQC, the Royal Colleges and academic research studies with the aim of supporting changes that can help improve the quality and safety of healthcare delivery.The programme will build on the work of the existing Medical and Surgical Clinical Outcome Review Programme. This programme began in 1988 as a co-operation between the Association of Anaesthetists and the Association of Surgeons who established a National Confidential Enquiry into Perioperative Deaths with an aim to examine the quality of care delivery to surgical and anaesthetic patients who had died in hospital within 30 days of a surgical procedure. In 1999 the programme transferred to the National Institute for Health and Clinical Excellence (NICE) and further to a consultation in 2002 the remit of the programme was extended to review the care received by medical patients as well as surgical patients. In addition near miss morbidity cases were included as well as cases of mortality. In 2005 responsibility for the programme transferred from NICE to the National Patient Safety Agency (NPSA) until 2011 when further to the closure of the NPSA, the responsibility for the commissioning and management of all the Clinical Outcome Review Programmes transferred to HQIP who manage the programmes on behalf of the funding bodies.2. OutlineThe successful supplier will consult and collaborate with relevant stakeholders to develop and run a programme that undertakes external anonymised case note review of medical and surgical patients by multidisciplinary professionals along the patient pathway including both primary and secondary care.Outputs will inform stakeholders on the quality of care provision and patient outcomes for medical and surgical patients in topic areas, identifying remedial factors and producing recommendations on how these can be addressed, targeted to specific groups. Outputs should link to and stimulate quality improvement work streams at both local and national level and support commissioning and service redesign. Key audiences will include clinicians, service users, their families and carers, and representative organisations, policy makers, commissioners, regulators and researchers.This programme must collaborate with other Clinical Outcome Review Programmes as relevant. In addition this programme must align with the National Clinical Audit and Patient Outcome Programme and be both informed by and inform National Clinical Audits as appropriate.A call for topics must be held annually and topics selected using a designated prioritisation process, approved by the funding bodies. The programme requires two reports per year to be published and made available in full in the public domain, excluding any information that might make individual patients identifiable.The following topics have already been selected for 2015/2016;— Gastrointestinal Haemorrhage;— Sepsis;— Acute Pancreatitis;— Provision of mental health care in acute hospitals.Tenderers will be expected to demonstrate how they will engage with and achieve input from those with relevant clinical and professional expertise to topic areas. In addition, involvement from a representative mix of service users, their family and carers and their representative organisations along the entire programme including planning, internal governance, outputs and dissemination is essential.Tenderers must also demonstrate how they will achieve clinical engagement and participation to facilitate the notification and submission of cases. Organisation level participation rates must be published with each report.Governance to the programme will be provided by the Medical and Surgical Clinical Outcome Review Programme Independent Advisory Group which includes representatives of the funding bodies together with academic and clinical expertise and service users.